Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Edward Sausville, MD

University of Maryland, Greenbaum Cancer Center

Related
1 trials

Shared therapeutic areas:

Neoplasm Metastasis

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score14%

Johana Bendell, MD

Sara Cannon Research Institute

Related
1 trials

Shared therapeutic areas:

Neoplasm Metastasis

Worked with same sponsors:

Mersana Therapeutics
Collaborated on 1 trial
Similarity Score14%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Neoplasm MetastasisCancer of Pancreas
Similarity Score9%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Neoplasm MetastasisCancer of Pancreas
Similarity Score9%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of PancreasSolid Tumors
Similarity Score9%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Related
22 trials

Shared therapeutic areas:

Neoplasm MetastasisSolid Tumors

Worked with same sponsors:

Eli Lilly and Company
Similarity Score9%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasSolid Tumor
Similarity Score9%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Solid TumorSolid Tumors

Worked with same sponsors:

Dana-Farber Cancer Institute
Similarity Score9%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of PancreasSolid Tumor
Similarity Score9%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Solid TumorSolid Tumors
Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03057145Phase 1PrincipalInvestigator

Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors

Solid Tumor
Completed
NCT03065062Phase 1PrincipalInvestigator

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Head & Neck CancerLung Cancer Squamous CellPancreatic Cancer+1 more
Suspended
NCT02552953Phase 1PrincipalInvestigator

A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers

Cancer
Completed
NCT01011972Phase 1PrincipalInvestigator

A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Neoplasm Metastasis
Completed

All 4 trials loaded